School of Public Health Dean Shawn Gibbs has led national and international research, training and policy related to responses to highly infectious diseases.
Thirty-one percent of respondents to a Texas A&M-led survey said they don’t intend to be vaccinated against COVID-19.
In a newly published study, researchers call for clinical trials of an FDA-approved heart medication.
Texas A&M engineering researchers seek to develop a ventilation control system to reduce the spread of the coronavirus in public buildings.
Virtual services, including telemedicine, have allowed providers to care for patients at home.
Texas A&M School of Public Health experts explain the effort to prevent COVID-19 from rebounding as the state reopens.
Students are learning how veterinarians around the state have changed their processes during COVID-19, and are creating disaster plans for their future practices.
Despite COVID-19, the hospital continues to help animals like Nadar the Arabian gelding.
The Agricultural and Food Policy Center at Texas A&M estimates some of the state's agricultural products could see losses of up to 40 percent.
Dr. Jeffrey Cirillo is leading a national team that hopes to repurpose an existing tuberculosis vaccine to fight the coronavirus. About 700 participants are needed in Texas for the clinical trial.
A Texas A&M researcher says results from clinical trials indicate that they could be an effective way to treat coronavirus patients who develop complications.
With classes moved online, students have continued honing their skills via video conference with their professors.
A combination of fear, service to others and technology have contributed to reduced hospital visits for cases unrelated to COVID-19. But a Texas A&M expert cautions against avoiding medical care altogether.